Page last updated: 2024-10-28

p-hydroxyamphetamine and Cognition Disorders

p-hydroxyamphetamine has been researched along with Cognition Disorders in 1 studies

p-Hydroxyamphetamine: Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
"Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection that may affect the brain."1.46Inhibition of indoleamine 2,3-dioxygenase 1/2 prevented cognitive impairment and energetic metabolism changes in the hippocampus of adult rats subjected to polymicrobial sepsis. ( Barichello, T; Comim, CM; Dal-Pizzol, F; Ferreira, GK; Freiberger, V; Generoso, JS; Michels, M; Mina, F; Quevedo, J; Streck, EL; Ventura, L, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Comim, CM1
Freiberger, V1
Ventura, L1
Mina, F1
Ferreira, GK1
Michels, M1
Generoso, JS1
Streck, EL1
Quevedo, J1
Barichello, T1
Dal-Pizzol, F1

Other Studies

1 other study available for p-hydroxyamphetamine and Cognition Disorders

ArticleYear
Inhibition of indoleamine 2,3-dioxygenase 1/2 prevented cognitive impairment and energetic metabolism changes in the hippocampus of adult rats subjected to polymicrobial sepsis.
    Journal of neuroimmunology, 2017, 04-15, Volume: 305

    Topics: Animals; Avoidance Learning; Cognition Disorders; Disease Models, Animal; Energy Metabolism; Explora

2017